Niels Andreasen

15.1k total citations · 1 hit paper
120 papers, 9.8k citations indexed

About

Niels Andreasen is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Niels Andreasen has authored 120 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Physiology, 53 papers in Psychiatry and Mental health and 41 papers in Molecular Biology. Recurrent topics in Niels Andreasen's work include Alzheimer's disease research and treatments (90 papers), Dementia and Cognitive Impairment Research (52 papers) and Cholinesterase and Neurodegenerative Diseases (21 papers). Niels Andreasen is often cited by papers focused on Alzheimer's disease research and treatments (90 papers), Dementia and Cognitive Impairment Research (52 papers) and Cholinesterase and Neurodegenerative Diseases (21 papers). Niels Andreasen collaborates with scholars based in Sweden, United States and United Kingdom. Niels Andreasen's co-authors include Kaj Blennow, Pia Davidsson, Eugeen Vanmechelen, Lennart Minthon, Hugo Vanderstichele, Henrik Zetterberg, Bengt Winblad, Anders Wallin, Camilla Hesse and Lars Rosengren and has published in prestigious journals such as PLoS ONE, Annals of Neurology and Scientific Reports.

In The Last Decade

Niels Andreasen

118 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease

1999 543 citations Niels Andreasen, Camilla Hesse et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Niels Andreasen Sweden	55	6.4k	3.7k	3.0k	1.7k	1.5k	120	9.8k
Erik Portelius Sweden	52	6.4k 1.0×	2.8k 0.8×	3.6k 1.2×	1.5k 0.9×	1.2k 0.8×	144	9.2k
Elizabeth H. Corder United States	28	6.7k 1.1×	2.9k 0.8×	3.6k 1.2×	1.5k 0.9×	824 0.5×	59	11.3k
Piotr Lewczuk Germany	49	6.3k 1.0×	4.2k 1.1×	2.8k 0.9×	1.8k 1.1×	1.4k 0.9×	177	10.4k
Merçé Boada Spain	44	5.0k 0.8×	2.1k 0.6×	2.2k 0.7×	1.8k 1.1×	950 0.6×	238	8.6k
Michael C. Irizarry United States	56	8.4k 1.3×	3.0k 0.8×	3.4k 1.1×	2.2k 1.3×	1.9k 1.3×	166	13.2k
Eric Siemers United States	45	7.2k 1.1×	4.5k 1.2×	2.6k 0.8×	1.7k 1.0×	1.7k 1.1×	167	12.0k
Pia Davidsson Sweden	51	5.0k 0.8×	2.8k 0.8×	3.6k 1.2×	1.2k 0.7×	1.1k 0.7×	118	8.7k
Ulf Andréasson Sweden	57	7.7k 1.2×	4.9k 1.3×	3.9k 1.3×	2.5k 1.5×	3.4k 2.2×	178	13.7k
Miloš D. Ikonomović United States	50	4.8k 0.8×	2.3k 0.6×	2.5k 0.8×	1.6k 0.9×	1.6k 1.0×	162	9.0k
Hugo Vanderstichele Belgium	57	10.8k 1.7×	6.6k 1.8×	4.6k 1.5×	2.5k 1.5×	2.0k 1.3×	156	14.8k

Countries citing papers authored by Niels Andreasen

Since Specialization

Citations

This map shows the geographic impact of Niels Andreasen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niels Andreasen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niels Andreasen more than expected).

Fields of papers citing papers by Niels Andreasen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niels Andreasen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niels Andreasen. The network helps show where Niels Andreasen may publish in the future.

Co-authorship network of co-authors of Niels Andreasen

This figure shows the co-authorship network connecting the top 25 collaborators of Niels Andreasen. A scholar is included among the top collaborators of Niels Andreasen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niels Andreasen. Niels Andreasen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shahim, Pashtun, Magnus Gren, Victor Liman, et al.. (2016). Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Scientific Reports. 6(1). 36791–36791. 276 indexed citations

Hansson, Oskar, Lennart Minthon, Niels Andreasen, et al.. (2016). A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer’s Disease. Journal of Alzheimer s Disease. 53(4). 1353–1363. 27 indexed citations

Lleó, Alberto, Enrica Cavedo, Lucilla Parnetti, et al.. (2014). Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases. Nature Reviews Neurology. 11(1). 41–55. 118 indexed citations

Rosén, Christoffer, Ulf Andréasson, Niklas Mattsson, et al.. (2012). Cerebrospinal Fluid Profiles of Amyloid β-Related Biomarkers in Alzheimer’s Disease. NeuroMolecular Medicine. 14(1). 65–73. 55 indexed citations

Eriksdotter, Maria, Bengt Linderoth, Göran Lind, et al.. (2012). Encapsulated Cell Biodelivery of Nerve Growth Factor to the Basal Forebrain in Patients with Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 33(1). 18–28. 106 indexed citations

Zetterberg, Madeleine, Malin von Otter, Mona Seibt Palmér, et al.. (2010). Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease. Molecular Neurodegeneration. 5(1). 11–11. 16 indexed citations

Landgren, Sara, Mona Seibt Palmér, Lennart Minthon, et al.. (2009). No Association of VEGF Polymorphims with Alzheimer’s Disease. NeuroMolecular Medicine. 12(3). 224–228. 7 indexed citations

Andreasen, Niels & Henrik Zetterberg. (2008). Amyloid-Related Biomarkers for Alzheimers Disease. Current Medicinal Chemistry. 15(8). 766–771. 26 indexed citations

Kadir, Ahmadul, Niels Andreasen, Ove Almkvist, et al.. (2008). Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Annals of Neurology. 63(5). 621–631. 102 indexed citations

10.

García‐Ayllón, María‐Salud, María Ximena Silveyra, Niels Andreasen, et al.. (2007). Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer’s disease. Journal of Neurochemistry. 101(6). 1701–1711. 25 indexed citations

11.

Vanderstichele, Hugo, K De Vreese, Kaj Blennow, et al.. (2006). Analytical performance and clinical utility of the INNOTEST® PHOSPHO-TAU(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. Clinical Chemistry and Laboratory Medicine (CCLM). 44(12). 1472–80. 131 indexed citations

12.

Davidsson, Pia, et al.. (2006). Clusterin in cerebrospinal fluid: Analysis of carbohydrates and quantification of native and glycosylated forms. Neurochemistry International. 48(8). 718–728. 81 indexed citations

13.

Feuk, Lars, Boo Johansson, Nenad Bogdanović, et al.. (2004). Variants of CYP46A1 may interact with age and APOE to influence CSF A�42 levels in Alzheimer?s disease. Human Genetics. 114(6). 581–587. 53 indexed citations

14.

Chalmers, Katy, Niels Andreasen, Nenad Bogdanović, et al.. (2004). Sequence variants of IDE are associated with the extent of β-amyloid deposition in the Alzheimer's disease brain. Neurobiology of Aging. 26(6). 795–802. 41 indexed citations

15.

Zetterberg, Henrik, Niels Andreasen, & Kaj Blennow. (2004). Increased cerebrospinal fluid levels of transforming growth factor-β1 in Alzheimer’s disease. Neuroscience Letters. 367(2). 194–196. 85 indexed citations

16.

Olsson, Annika, Kina Höglund, Magnus Sjögren, et al.. (2003). Measurement of α- and β-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients. Experimental Neurology. 183(1). 74–80. 109 indexed citations

17.

Andreasen, Niels, Magnus Sjögren, & Kaj Blennow. (2003). CSF markers for Alzheimer's disease: Total tau, phospho-tau and Aβ42. The World Journal of Biological Psychiatry. 4(4). 147–155. 96 indexed citations

18.

Andreasen, Niels & Kaj Blennow. (2002). β-Amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer’s disease. Peptides. 23(7). 1205–1214. 64 indexed citations

19.

Davidsson, Pia, Ann Brinkmalm, Carol L. Nilsson, et al.. (2002). Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients. Neuroreport. 13(5). 611–615. 175 indexed citations

20.

Davidsson, Pia, Kaj Blennow, Niels Andreasen, et al.. (2001). Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease. Neuroscience Letters. 300(3). 157–160. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact